Category
Cancer
Sub Category
Glioblastoma
Study Name
A071101: A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 Vaccine Given with Bevacizumab versus Bevacizumab Alone in the Treatment of Surgically Resective Recurrent Glioblastoma Multiforme.
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance